Featured Research

from universities, journals, and other organizations

Genetic variation alters efficacy of antidepressant

Date:
October 22, 2013
Source:
Society for Neuroscience
Summary:
Having a different form of a gene that regulates the brain chemical noradrenaline influences how well men remember negative memories after taking the antidepressant drug reboxetine, according to a study. The findings demonstrate how genes can influence antidepressant response.

Having a different form of a gene that regulates the brain chemical noradrenaline influences how well men remember negative memories after taking the antidepressant drug reboxetine, according to a study published in the October 23 issue of The Journal of Neuroscience. The findings demonstrate how genes can influence antidepressant response.

Related Articles


While it is normal for our strongest memories to be associated with emotional experiences, previous studies suggest the heightened recall of negative events may be linked to depression and anxiety disorders. Research also shows that reboxetine, which exclusively affects brain levels of noradrenaline, reduces the tendency of people with depression to recall negative memories.

In the current study, Ayana Gibbs, MD, PhD, Theodora Duka, MD, PhD, and others at the University of Sussex examined how reboxetine influences emotional memories in healthy men with a variant form of the α-2B adrenoceptor gene (ADRA2B), which contains the instructions for a type of noradrenaline receptor. The researchers found that while reboxetine weakened aversive memory in people with the common form of ADRA2B, the drug did not change aversive memory in people with the variant gene form.

"Researchers are increasingly interested in how antidepressants like reboxetine affect the way emotional information is processed and how this information could be used to predict the drugs that are most likely to be successful antidepressants," Gibbs said. "Our study suggests genetic makeup is another important piece of the puzzle."

More than 100 healthy white men participated in the University of Sussex study, where they received a genetic test to see if they had the ADRA2B variant (30 percent of whites do). They were then randomly assigned to receive a single dose of reboxetine or a sugar (placebo) pill. After waiting a couple of hours for the drug to be absorbed into the bloodstream, the men viewed a series of positive, negative, and neutral images on a computer screen. Such images included pictures of children riding a rollercoaster ride, the scene of an accident, and a man looking out of a window. Thirty minutes later, they were asked to write descriptions of as many pictures as they could remember.

While all participants remembered the positive and negative pictures better than the neutral ones, the participants with the ADRA2B variant recalled more negative pictures -- an effect that remained even in those who received the reboxetine treatment.

"This study is good news for the scientific community, which has struggled for decades to identify factors influencing the admittedly moderate efficacy of antidepressants," explained Andreas Papassotiropoulos, MD, who studies how genes influence memory at the University of Basel and was not involved with this study. "This study elegantly demonstrates the importance of the concept of aversive memory in psychiatric disease and paves the way for further experiments dealing with the molecular underpinnings of antidepressant efficacy," he added.

According to Gibbs, future studies will explore whether the ADRA2B variant influences the effectiveness of reboxetine in other groups, including women, and establish whether similar effects are observed in patients with depression or anxiety disorders.


Story Source:

The above story is based on materials provided by Society for Neuroscience. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. A. Gibbs, C. E. Bautista, F. D. Mowlem, K. H. Naudts, T. Duka. Alpha 2B Adrenoceptor Genotype Moderates Effect of Reboxetine on Negative Emotional Memory Bias in Healthy Volunteers. Journal of Neuroscience, 2013; 33 (43): 17023 DOI: 10.1523/JNEUROSCI.2124-13.2013

Cite This Page:

Society for Neuroscience. "Genetic variation alters efficacy of antidepressant." ScienceDaily. ScienceDaily, 22 October 2013. <www.sciencedaily.com/releases/2013/10/131022183250.htm>.
Society for Neuroscience. (2013, October 22). Genetic variation alters efficacy of antidepressant. ScienceDaily. Retrieved February 28, 2015 from www.sciencedaily.com/releases/2013/10/131022183250.htm
Society for Neuroscience. "Genetic variation alters efficacy of antidepressant." ScienceDaily. www.sciencedaily.com/releases/2013/10/131022183250.htm (accessed February 28, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Saturday, February 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Foods to Battle Stress

The Best Foods to Battle Stress

Buzz60 (Feb. 26, 2015) If you&apos;re dealing with anxiety, there are a few foods that can help. Krystin Goodwin (@krystingoodwin) has the best foods to tame stress. Video provided by Buzz60
Powered by NewsLook.com
Sleeping Too Much Or Too Little Might Increase Stroke Risk

Sleeping Too Much Or Too Little Might Increase Stroke Risk

Newsy (Feb. 26, 2015) People who sleep more than eight hours per night are 45 percent more likely to have a stroke, according to a University of Cambridge study. Video provided by Newsy
Powered by NewsLook.com
Mayor Says District of Columbia to Go Ahead With Pot Legalization

Mayor Says District of Columbia to Go Ahead With Pot Legalization

Reuters - News Video Online (Feb. 25, 2015) Washington&apos;s mayor says the District of Columbia will move forward with marijuana legalization, despite pushback from Congress. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Marijuana Nowhere Near As Deadly As Alcohol: Study

Marijuana Nowhere Near As Deadly As Alcohol: Study

Newsy (Feb. 25, 2015) A new study says marijuana is about 114 times less deadly than alcohol. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins